Full Text View
Tabular View
No Study Results Posted
Related Studies
Sorafenib for Patients With Extensive Keloids
This study is not yet open for participant recruitment.
Verified June 2012 by Tirgan, Michael H., M.D.
Study NCT01425216   Information provided by Tirgan, Michael H., M.D.

First Received on August 19, 2011.   Last Updated on June 6, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Keloids
Additional conditions recognized in this trial
Keloid
More general conditions related to this trial
Cicatrix
Collagen Diseases
Connective Tissue Diseases
Fibrosis
Pathologic Processes
Interventions listed in this trial
Sorafenib
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Kinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Tirgan, Michael H., M.D.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services